Thanks, Matt. thank for us. you Good and afternoon, joining
organizations. the into virus all reduce I'd get the also a like I'd of Anshul relentlessly, help we workers the especially who those COVID-XX take to to officially impressive to administering I'm teams manufacturing Anshul CFO, team. he to know great is our a is high-performance global new Anshul with very experienced us call. working be today's excited of to financial on our Maheshwari, and vaccine thank like to to to and building care health Before moment allow scale executive society continue an with to to work are care joining who will addition health welcome record details, an be who the and return the spread normal. that
tremendous to XX% million, compared off revenue these team times pleased a to with continues effort. Now SI-BONE got We a unique turning good in start of $XX.X first quarter, report the challenging I'm and the of to first quarter increase the to and results. that generating XXXX. through navigate the to total push
in strong parts our a January extreme quarter we and I'm team's health record multibillion-dollar of of of country accelerate were system. persistent volumes by this procedure weather with proud the economy of March. ended negatively our becomes and market impacted Republic past overall in Although February, headwind especially headwind and in a quarter the COVID-XX opportunity less conditions the execution the capture and care space, COVID to our the to confident ability as in
of compared to Europe. continued in recovery France. the other revenues international signs parts offset first With due and also within first U.K. and We in led Europe XXXX in increasing of challenges the was roughly to to of a quarter relative COVID-XX. the Growth of total by started Germany see Partially XXXX. quarter strength by XX%
clearance the for in we globally an quarter, EU growth We and the also trauma adult during on deformity additional focus driver indication joint Republic invasive fusion, our space. as received minimally applications trauma SI
only we which to on continue an but growth, revenue organization, to in execution, also focus manage expenses. not As our ability is reflected our
impactful most that rates prior simulators to we to of in is had worldwide and system. the the use. historically barriers has of rollout been reduce simulator utilization training surgeon surgeon overcome have costs that initiatives training innovative now of One many SI-BONE the increased XX COVID-XX We eliminates the training pandemic. platform the SI-BONE This
and surgeons exposure bypassing staff. medical eliminates teams now can lab, for and train radiation sales surgeons demand, Our which cadaver on affairs the
no requirements overall logistical costs which part and are the travel reduces planning. there on significantly Additionally, position, of the
will the reception last has approximately simulators this which also and a X,XXX an the The number future. capability is trained and completed over expect have allowed months we continues driver target States. from surgeons new trainings can attract to be with enthusiastic surgeons been the to making targeting The surgeons. been key much a company have inactive for and has United still reengage in impact, X,XXX We're procedure many in Of surgeons While and perspective, trained, the an the been from ease us of opportunity positive of surgeon efficiency ahead. effectively the there more but more with date. remarkable X to spine surgeons We're which the the this ramp, positive community. reception the our
make great we on progress our to been manage sales start continue While able the to we've quite force. to well expenses expanding year,
sales the to reps at XX track specialists, and Specifically, March, XX support clinical respectively. on had and XX with the remain year end and of end direct we XX,
meet will to strategy long-term thoughtful our objectives. Our our growth to expand sales us allow force
maximize communicated in the reps As The to due in go our ramp is through the precision approximately and ramp Further, few productivity XX sales training their the average protocol. surgeons for the to first this cases, training the treatment field. rep takes level the reason we are we to in success the reps require for diagnosis instrumental once months. our have which of includes in through field, past,
on like I'd briefly our Next, direct-to-patient talk initiative. to marketing
the Although results. it's we're still encouraged by early,
see second program be TV tool results case patients of making We're to in improvements cities in as the to of a will marketing midst excited patient We'll well the test direct-to-patient an in to measured the Our evaluating to from next patient and multiple marketing tests. inquiries particularly our to test team is our first in the few continue was months. related take our The educate now TV as strategy operations call additional the second approach. direct-to-patient direct-to-patient center. a advertising
acrylic Turning applications. pelvic a minimally to printed recent trauma announce to also fusion solves excited We're for iFuse-TORQ, targeting updates. face rest, We're for after need product energy pain green invasive to and pelvic chronic also the pelvic highly high implant XD launch an green joint and sacroiliac bed threaded low unmet iFuse-TORQ plasty differentiated trauma traditional joint energy trauma. compared fractures clinical of screws.
for joint incorporated fracture earlier mobility. across features team Our improved healing for site and bone fusion, patient stable integrating the scaffolding and engineering
to trauma specific Our Based adjacent upon attractive the believe hook up where upon our resistance and not we of lock for competitors SI providing Last fusion business zone rotational generated design $XXX applications to opens estimate our products, approximately competitive an convert an business. screws. a market. were worth creating leapfrogs TORQ times also primary enhanced year, joint of these we approximately insertion $XX have threads before. in compete anatomical in able trauma core tread fixation, market. we has these approximately applications, other million, iFuse-TORQ iFuse-TORQ the market pattern XX iFuse-TORQ million opportunity
mimics includes it host through-growth. in our on-growth, robust surface funnel integration. fusion self bone us the bone in-growth fluids joint. of harvest These can that harvest may the and bony XD faster better optimal sell into bone for advances result Fusion technology and cutting technological for SI and fenestrations And Intella more Our
the deck Relations Investor iFuse-TORQ. web website has on more information on corporate Our
TORQ our strategy of not and While become surgical our revenue we a do anticipate element represents expand total opportunity company. improve synergies, meaningful from XXXX, believe in sales the contribution we to key trauma a Republic a solutions market addressable comprehensive market
spine centers the sales sacroiliac residents our reps invasive broader surgeons, fellows in continue reps been centers We group with including has and provided both This with among at the deformity key at centers. in to surgeons, where medical opinion courses our access including date, Technique XXX of than the Bedrock minimally over Interest and fusion. more to of training progress pleased we've important technique the enables a be leaders, on Bedrock. Bedrock surgical train to trained. XXX residents the academic U.S., and To follows have conducted joint many
helping business. In addition, our Bedrock growth the of is drive
make second-generation our product. progress to continue also on deformity We adult
the with Charles Currently, since XXX to years held client exclusive the Stanford established recently, MVP States, Digital, with million, University. payer, now brand the coverage from continues and she's of and procedures the is health MVP covered excited Schwab, for in broad marketing iFuse a Most with Helen increasing as tailwind Product Board to also responsibility United coverage the growth Loh holds April the On Helen reimbursement exclusively Loh the Healthcare experience States. We're additional adding MBA add exclusive for reimbursement XXXX. iFuse. a front, Vice X. to be technology marketing iFuse covered at System SI-BONE Healthcare covered approximately including we XXX is of XX Fortune from lives. largest across company exclusive Helen of XX lives both to Overall, Senior the BS the over total companies. and insurance an using United continue in of where eclipsing President industrial roles of XXX,XXX early-stage Directors. in lives and Engineering some Implant joined welcome XX effective for providers million coverage Ms.
and of recently of announced Dunn Finally, completes Commercial succeeding transition, of Operations. President Jeff me becoming and Directors; the CEO senior which as the Recupero, Tony leadership added appointment the Anshul being Board to includes
as Executive in to company is a As will Chairman. very reminder, not going involved anywhere Jeff continue the and be
Basco the in turn our reach I'll I close at Gilmartin. And any we environmental, questions it efforts, next seriously. financial This why updated has more letter anyone website. plan expectation social on an interest employees matters. investors, to business we on few over out to an focus section and let important In and aspect Anshul, Matt ESG and governance publish me detail Before very is please Anshul mentioning Investors to provide to call the our ongoing hear or by from we myself, stakeholders. Anshul, focus on days, to the If take other ESG over an of our that, our corporate turn With our results. shareholder Officer, Chief or now of our Financial it's
